(Q37087365)

18 August 2017

1 reference

title

Cost-effectiveness analyses of vaccination programmes : a focused review of modelling approaches (English)

1 reference

cost-effectiveness analysis

18 August 2017

1 reference

2

Sue J Goldie

1 reference

18 August 2017

Sun-Young Kim

1

1 reference

18 August 2017

1 January 2008

1 reference

18 August 2017

1 reference

18 August 2017

26

1 reference

18 August 2017

3

1 reference

18 August 2017

191-215

1 reference

https://scigraph.springernature.com/pub.10.2165/00019053-200826030-00004

18 August 2017

0 references

cites work

Are differences in practitioners' acceptance of a quality assurance intervention related to their performance?

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00019053-200826030-00004

Economic evaluations of pneumococcal vaccination strategies in adults. A summary of the results

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00019053-200826030-00004

Modeling the impact of adjuvant therapy and screening mammography on U.S. breast cancer mortality between 1975 and 2000: introduction to the problem

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00019053-200826030-00004

A guide to cost-effectiveness acceptability curves.

21 January 2018

1 reference

12 December 2020

Accounting for future costs in medical cost-effectiveness analysis

1 reference

12 December 2020

Cost-effectiveness analysis: can we reduce variability in costing methods?

1 reference

12 December 2020

Impact of model, methodological, and parameter uncertainty in the economic analysis of vaccination programs

1 reference

12 December 2020

Review of the cost effectiveness of immunisation strategies for the control of epidemic meningococcal meningitis

1 reference

12 December 2020

Validation of health economic models: the example of EVITA.

1 reference

12 December 2020

Programme costs in the economic evaluation of health interventions

1 reference

12 December 2020

Alternative decision modelling techniques for the evaluation of health care technologies: Markov processes versus discrete event simulation

1 reference

12 December 2020

Stochastic league tables: communicating cost-effectiveness results to decision-makers

1 reference

12 December 2020

Modelling in economic evaluation: an unavoidable fact of life

1 reference

12 December 2020

A review of health care models for coronary heart disease interventions

1 reference

12 December 2020

An agent-based model of sleeping sickness: simulation trials of a forest focus in southern Cameroon

1 reference

12 December 2020

Chapter 18: Public health policy for cervical cancer prevention: the role of decision science, economic evaluation, and mathematical modeling

1 reference

12 December 2020

Role of herd immunity in determining the effect of vaccines against sexually transmitted disease

1 reference

12 December 2020

An introduction to mathematical models in sexually transmitted disease epidemiology

1 reference

12 December 2020

Enhancing the comparability of costing methods: cross-country variability in the prices of non-traded inputs to health programmes

1 reference

12 December 2020

Cost-effectiveness of HPV 16, 18 vaccination in Brazil

1 reference

12 December 2020

Multiparameter Calibration of a Natural History Model of Cervical Cancer

1 reference

12 December 2020

Estimating the costs of achieving the WHO-UNICEF Global Immunization Vision and Strategy, 2006-2015.

1 reference

12 December 2020

Vaccinating healthcare workers against influenza to protect the vulnerable--is it a good use of healthcare resources? A systematic review of the evidence and an economic evaluation.

1 reference

12 December 2020

Use of modeling to evaluate the cost-effectiveness of cancer screening programs

1 reference

12 December 2020

Mathematical models for predicting the epidemiologic and economic impact of vaccination against human papillomavirus infection and disease

1 reference

12 December 2020

Health economic research on vaccinations and immunisation practices--an introductory primer

1 reference

12 December 2020

Representing uncertainty: the role of cost-effectiveness acceptability curves.

1 reference

12 December 2020

Modelling in the economic evaluation of health care: selecting the appropriate approach

1 reference

12 December 2020

The role of economic evaluation in vaccine decision making: focus on meningococcal group C conjugate vaccine

1 reference

12 December 2020

Limitations of acceptability curves for presenting uncertainty in cost-effectiveness analysis

1 reference

12 December 2020

Good practice guidelines for decision-analytic modelling in health technology assessment: a review and consolidation of quality assessment

1 reference

12 December 2020

Economic evaluations applied to HB vaccination: general observations

1 reference

12 December 2020

Mathematical models of the transmission and control of sexually transmitted diseases

1 reference

12 December 2020

Assessing quality in decision analytic cost-effectiveness models. A suggested framework and example of application

1 reference

12 December 2020

Methodological issues and new developments in the economic evaluation of vaccines

1 reference

12 December 2020

Cost-effectiveness acceptability curves--facts, fallacies and frequently asked questions

1 reference

12 December 2020

Review of guidelines for good practice in decision-analytic modelling in health technology assessment

1 reference

12 December 2020

Economic analyses of rubella and rubella vaccines: a global review.

1 reference

12 December 2020

Evaluating the cost-effectiveness of vaccination programmes: a dynamic perspective

1 reference

12 December 2020

Cost-effectiveness of hepatitis A vaccination in children, adolescents, and adults

1 reference

12 December 2020

Empirically calibrated model of hepatitis C virus infection in the United States

1 reference

12 December 2020

Financial challenges of immunization: a look at GAVI.

1 reference

12 December 2020

Transmission dynamics and control of severe acute respiratory syndrome

1 reference

12 December 2020

Pharmaco-economic evaluation of targeted hepatitis A vaccination for children of ethnic minorities in Amsterdam (The Netherlands).

1 reference

12 December 2020

Bacterial vaccines and serotype replacement: lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae

1 reference

12 December 2020

Canada's new guidelines for the economic evaluation of pharmaceuticals

1 reference

12 December 2020

Searching literature databases for health care economic evaluations: how systematic can we afford to be?

1 reference

12 December 2020

Economic evaluation of vaccination programmes: a consensus statement focusing on viral hepatitis

1 reference

12 December 2020

Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccination

1 reference

12 December 2020

Thinking outside the box: recent advances in the analysis and presentation of uncertainty in cost-effectiveness studies

1 reference

12 December 2020

Are economic evaluations of vaccines useful to decision-makers? Case study of Haemophilus influenzae type b vaccines

1 reference

12 December 2020

Modeling for health care and other policy decisions: uses, roles, and validity

1 reference

12 December 2020

A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine

1 reference

12 December 2020

An off-the-shelf help list: a comprehensive catalog of preference scores from published cost-utility analyses.

1 reference

12 December 2020

Analysis and simulation of a stochastic, discrete-individual model of STD transmission with partnership concurrency.

1 reference

12 December 2020

Markov models in medical decision making: a practical guide.

1 reference

12 December 2020

Representing both first- and second-order uncertainties by Monte Carlo simulation for groups of patients

1 reference

12 December 2020

Generalisability in economic evaluation studies in healthcare: a review and case studies.

1 reference

12 December 2020

Cost valuation in resource-poor settings

1 reference

12 December 2020

Economic evaluation of vaccination programs: the impact of herd-immunity

1 reference

12 December 2020

A synthesis of cost-utility analysis literature in infectious disease

1 reference

12 December 2020

Setting priorities for the Children's Vaccine Initiative: a cost-effectiveness approach

1 reference

12 December 2020

Allowing for uncertainty in economic evaluations: qualitative sensitivity analysis

1 reference

12 December 2020

Cost-effectiveness analyses of human papillomavirus vaccination

1 reference

12 December 2020

The cost-effectiveness of screening programs using single and multiple birth cohort simulations: a comparison using a model of cervical cancer

1 reference

12 December 2020

Theory and methods of economic evaluation of health care

1 reference

12 December 2020

The value of including boys in an HPV vaccination programme: a cost-effectiveness analysis in a low-resource setting

1 reference

12 December 2020

Cost-effectiveness analysis and health care resource allocation: decision rules under variable returns to scale

1 reference

12 December 2020

Quality of systematic reviews of economic evaluations in health care

1 reference

12 December 2020

Report from the Canadian Coordinating Office for Health Technology Assessment (CCOHTA). Guidelines for economic evaluation of pharmaceuticals: Canada

1 reference

12 December 2020

Convincing or confusing? Economic evaluations of childhood pneumococcal conjugate vaccination--a review (2002-2006).

1 reference

12 December 2020

Economic evaluations of varicella vaccination programmes: a review of the literature

1 reference

12 December 2020

Agent-based modeling: methods and techniques for simulating human systems

1 reference

12 December 2020

Econometric estimation of country-specific hospital costs

1 reference

12 December 2020

Economic evaluations of hepatitis B immunization: a global review of recent studies (1994-2000).

1 reference

12 December 2020

The use of modeling to understand the impact of screening on U.S. mortality: examples from mammography and PSA testing.

1 reference

12 December 2020

Varicella vaccination in Italy : an economic evaluation of different scenarios

1 reference

12 December 2020

Uncertainty in cost-effectiveness analysis. Probabilistic uncertainty analysis and stochastic league tables

1 reference

12 December 2020

Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis

1 reference

12 December 2020

The Wisconsin Breast Cancer Epidemiology Simulation Model

1 reference

12 December 2020

Growth and quality of the cost-utility literature, 1976-2001.

1 reference

12 December 2020

Economic aspects of pneumococcal pneumonia: a review of the literature.

1 reference

12 December 2020

The costs, effects and cost-effectiveness of strategies to increase coverage of routine immunizations in low- and middle-income countries: systematic review of the grey literature.

1 reference

12 December 2020

Cost effectiveness of rotavirus vaccines and other interventions for diarrhoeal diseases: meeting report 2006

1 reference

12 December 2020

Cost-effectiveness of rotavirus vaccines

1 reference

12 December 2020

A comprehensive league table of cost-utility ratios and a sub-table of "panel-worthy" studies

1 reference

12 December 2020

Chapter 21: Modelling the impact of HPV vaccines on cervical cancer and screening programmes

1 reference

12 December 2020

Cost-effectiveness acceptability curves in the dock: case not proven?

1 reference

12 December 2020

Development and validation of a grading system for the quality of cost-effectiveness studies

1 reference

12 December 2020

Methods to assess the costs and health effects of interventions for improving health in developing countries

1 reference

12 December 2020

Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies.

1 reference

12 December 2020

Costs of scaling up health interventions: a systematic review

1 reference

12 December 2020

Valuing prevention through economic evaluation: some considerations regarding the choice of discount model for health effects with focus on infectious diseases

1 reference

12 December 2020

Economic evaluation of communicable disease interventions in developing countries: a critical review of the published literature.

1 reference

12 December 2020

Economic burden of pertussis and the impact of immunization

1 reference

12 December 2020

Theoretical epidemiologic and morbidity effects of routine varicella immunization of preschool children in the United States

1 reference

12 December 2020

Recent developments in decision-analytic modelling for economic evaluation

1 reference

12 December 2020

A taxonomy of model structures for economic evaluation of health technologies.

1 reference

12 December 2020

10.2165/00019053-200826030-00004

Identifiers

DOI

1 reference

release_w5kretvweza75gpozkklku3rau

18 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/w5kretvweza75gpozkklku3rau

24 November 2022

mapped directly with Wikidata item

PubMed ID

18282015

1 reference

PubMed ID

18282015